| Birth Place: | New Glasgow, Nova Scotia, Canada |
| Occupation: | Physician |
| Alma Mater: | Dalhousie University[1] |
David Juurlink (;[2] born New Glasgow, Nova Scotia) is a Canadian pharmacologist and internist. He is head of the Clinical Pharmacology and Toxicology division at Sunnybrook Health Sciences Centre in Toronto, Ontario, as well as a medical toxicologist at the Ontario Poison Centre and a scientist at the Institute for Clinical Evaluative Sciences. He is known for researching adverse effects caused by drug interactions, with some of this research funded by a New Investigator Award from the Canadian Institutes for Health Research.[3] He has been very critical of his fellow physicians' regular prescribing of dangerous opioids like Tramadol[4] and fentanyl.[5] [6] In June 2017, he published a letter analyzing citations to "Addiction Rare in Patients Treated with Narcotics", a 1980 letter in The New England Journal of Medicine that has often been cited to claim that opioids like OxyContin are rarely addictive.[7]